Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Selectin ligand antagonist TBC-1269 attenuates renal ischemic reperfusion injury in rats

Nov. 9, 1999

Vasopressin antagonist VPA-985: summary of clinical data presented at ASN

Nov. 9, 1999

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Nov. 8, 1999

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Nov. 8, 1999

Agents for urinary incontinence, pollakiuria in early development at Fujisawa

Nov. 4, 1999

U Penn researchers identify new target for treatment of erectile dysfunction

Nov. 2, 1999

Proof-of-concept trial begins for Vivus's oral PE compounds

Oct. 21, 1999

AnorMed initiates phase III clinical trials in U.S. for Lambda

Oct. 20, 1999

FDA approves Rochester Medical's FemSoft Insert for female stress urinary incontinence

Oct. 5, 1999

New muscarinic antagonists developed at Roche

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...